No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis

Abstract Cognitive impairment is an important predictor of disability in schizophrenia. Dopamine neurotransmission in cortical brain regions has been suggested to be of importance for higher-order cognitive processes. The aim of this study was to examine the relationship between extrastriatal dopami...

Full description

Bibliographic Details
Main Authors:	Maria Lee, Helena Fatouros-Bergman, Pontus Plavén-Sigray, Pauliina Ikonen Victorsson, Carl M. Sellgren, Sophie Erhardt, Lena Flyckt, Lars Farde, Simon Cervenka
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-09-01
Series:	npj Schizophrenia
Online Access:	https://doi.org/10.1038/s41537-021-00176-x

Similar Items

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
by: Meneca Becklén, et al.
Published: (2021-04-01)

[11C]SCH23390 binding to the D1-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis
by: Per Stenkrona, et al.
Published: (2018-08-01)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
by: Fernando R. Malinowski, et al.

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study.
by: Pontus Plavén-Sigray, et al.
Published: (2018-01-01)

Neurite Orientation Dispersion and Density Imaging (NODDI) and duration of untreated psychosis in antipsychotic medication-naïve first episode psychosis patients
by: Nina Vanessa Kraguljac, et al.
Published: (2021-03-01)

Satisfaction with antipsychotic medication in first episode psychosis
by: Meek, Ian Tod
Published: (2011)

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
by: Chengai Xu, et al.
Published: (2020-06-01)

Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals
by: Luccas S. Coutinho, et al.
Published: (2019-06-01)

Are depot as effective as oral antipsychotics on first-episode psychosis?
by: Cristián Orus, et al.
Published: (2016-06-01)

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function
by: Pontus Plavén-Sigray, et al.
Published: (2018-11-01)

Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data
by: Granville J. Matheson, et al.
Published: (2017-07-01)

Hair cortisol in drug-naïve first-episode individuals with psychosis
by: Elvis H. Andrade, et al.
Published: (2016-03-01)

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
by: Kärt Kriisa, et al.
Published: (2016-01-01)

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
by: Piotr Marcinowicz, et al.
Published: (2021-06-01)

Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [11C]FLB 457
by: Tove Freiburghaus, et al.
Published: (2021-02-01)

Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment
by: Wenbin Li, et al.
Published: (2018-01-01)

Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
by: Fiona Boland, et al.
Published: (2021-01-01)

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients
by: Helle G. Andersen, et al.
Published: (2020-05-01)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
by: Adam UU, et al.
Published: (2014-10-01)

EEG Microstate Differences in Medicated vs. Medication-Naïve First-Episode Psychosis Patients
by: Amatya J. Mackintosh, et al.
Published: (2020-11-01)

Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis
by: Maria Giuseppina Petruzzelli, et al.
Published: (2018-08-01)

Magnetization transfer imaging alterations and its diagnostic value in antipsychotic-naïve first-episode schizophrenia
by: Ai, Y., et al.
Published: (2022)

Neuroinflammation and psychosis : antipsychotic medication
by: Bloomfield, Peter S.
Published: (2015)

Serotonin transporter availability increases in patients recovering from a depressive episode
by: Jonas E. Svensson, et al.
Published: (2021-05-01)

Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
by: Liisa Leppik, et al.
Published: (2018-04-01)

The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals
by: María Juncal-Ruiz, et al.
Published: (2018-02-01)

In response to the letter “[11C]raclopride and extrastriatal binding to D2/3 receptors”
by: Jonas E. Svensson, et al.
Published: (2020-02-01)

Methamphetamine psychosis, the efficacy of atypical antipsychotics
by: Amir Rezaei Ardani, et al.
Published: (2014-12-01)

Effects of Long-Term Multimodal Psychosocial Treatment on Antipsychotic-Induced Metabolic Changes in Patients With First Episode Psychosis
by: Martina Rojnic Kuzman, et al.
Published: (2018-10-01)

Auditory Event-Related Potentials in Antipsychotic-Free Subjects With Ultra-High-Risk State and First-Episode Psychosis
by: Ming H. Hsieh, et al.
Published: (2019-04-01)

A study of soft neurological signs and its correlates in drug-naive patients with first episode psychosis
by: Vanishree Gunasekaran, et al.
Published: (2016-01-01)

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method
by: M. Randau, et al.
Published: (2019-01-01)

A longitudinal comparison of the metabolic characteristics of outpatients with first episode psychosis taking second generation antipsychotics : an interim analysis
by: Whitney, Zachary
Published: (2015)

Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients
by: Xiang Zhou, et al.
Published: (2020-07-01)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
by: Dimy Fluyau, et al.
Published: (2019-10-01)

Thalamic shape abnormalities in antipsychotic naïve schizophrenia
by: Vijay Danivas, et al.
Published: (2013-01-01)

Entorhinal cortex volume in antipsychotic-naïve schizophrenia
by: Sam P Jose, et al.
Published: (2012-01-01)

Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis
by: Chen-Chung Liu, et al.
Published: (2021-09-01)

First-episode psychosis: An update
by: Bonga Chiliza, et al.
Published: (2008-03-01)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
by: Jinguang Li, et al.
Published: (2020-10-01)